Domatinostat tosylate

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameDomatinostat tosylate
Drug Alias Namedomatinostat4SC-202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 2 inhibitorsHistone deacetylase 3 inhibitorsHistone deacetylase 1 inhibitors
TargetsHistone deacetylase 2Histone deacetylase 1Histone deacetylase 3
Therapy Area/IndicationsHematologic NeoplasmsGastrointestinal NeoplasmsCarcinoma, Transitional Cell +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesNetherlands +[10] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co LtdNycomed Pharmaceutical
China Registration ClassN/A

Develop Information

Active CompaniesThe Netherlands Cancer Institute4sc Ag
Inactive CompaniesN/A
Active IndicationsCarcinoma, Transitional CellMelanoma
Inactive IndicationsHematologic NeoplasmsGastrointestinal NeoplasmsNeoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A